论文部分内容阅读
目的探索泰乐口服液对晚期食管癌放射治疗患者生活质量的影响。方法应用泰乐口服液联合放疗40例食管癌患者,与单纯放疗食管癌患者进行分析比较。结果泰乐口服液明显改善和提高了晚期食管癌患者的生活质量,泰乐口服液合并放疗总有效率为93%,完全缓解率68%,单纯放疗组总有效率78%,完全缓解率51%。治疗中白细胞下降的发生率联合组少于单放组(P<0.01)。肝肾功能、心电图异常变化联合组无一例发生,而单放组分别为3例和4例。胃肠道反应两组差异无统计学意义。结论泰乐口服液与放疗联合应用治疗晚期食管癌患者,能提高患者的生活质量。
Objective To explore the effect of Tailou Oral Liquid on the quality of life of patients with advanced esophageal cancer treated by radiotherapy. Methods 40 patients with esophageal cancer were treated with Tai Lok Oral Liquid in combination with radiotherapy, and compared with radiotherapy and esophageal cancer alone. The results Taili oral solution significantly improved and improved the quality of life of patients with advanced esophageal cancer, Tail Lok oral solution combined with the total effective rate of 93% of radiotherapy, complete remission rate of 68%, radiotherapy alone group total effective rate of 78%, the complete remission rate of 51 %. The incidence of leukopenia in the treatment group was lower than that in the radiotherapy group (P <0.01). Liver and kidney function, ECG abnormalities in the combined group no one occurred, while the single group were 3 cases and 4 cases. Gastrointestinal reaction between the two groups showed no significant difference. Conclusion Tai Lok oral solution and radiotherapy combined with the treatment of advanced esophageal cancer patients, can improve the quality of life of patients.